SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-12 |
| Reported value | $2,901,979,696 |
| Positions | 97 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| KRYSTAL BIOTECH INC | KRYS | COM | $349,092,534 | 939,254 |
| CELCUITY INC | CELC | COM | $178,305,749 | 1,704,318 |
| TG THERAPEUTICS INC | TGTX | COM | $160,858,551 | 2,927,895 |
| INSULET CORP | PODD | COM | $159,710,250 | 1,049,000 |
| NOVOCURE LTD | NVCR | ORD SHS | $150,188,025 | 9,913,401 |
| UNITED THERAPEUTICS CORP DEL | UTHR | COM | $122,229,804 | 225,587 |
| INSPIRE MED SYS INC | INSP | COM | $86,161,360 | 1,931,436 |
| RIGEL PHARMACEUTICALS INC | RIGL | COM | $72,117,876 | 1,843,504 |
| ANI PHARMACEUTICALS INC | ANIP | COM | $71,833,173 | 867,760 |
| BETA BIONICS INC | BBNX | COM | $68,849,498 | 4,393,714 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.